Matthew Kelleher, MD
Dermatology · Crest Hill, ILNPI 1225022882
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 98.0% of the total across 39 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 11 manufacturers reported payments, led by Novartis at 47.9% of the total. Reporting peaked in 2023 at $482 and has fallen 94.2% since, to $28 in 2025. That places this record below the midpoint for dermatology clinicians in IL, where the typical reported total is $1,774.
Across 39 payments — averaging $19.33 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novartis$361
- AbbVie$99
- Merz North America, Inc.$84
- Galderma Laboratories, L.p.$38
- Sanofi$31
- Amgen$28
- plus $114 from 5 others
What the payments were for
- Food & beverage$73998%
- Education$152%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novartis | 22 | $361 |
| AbbVie(2 entities) | 5 | $99 |
| Merz North America, Inc. | 1 | $84 |
| Galderma Laboratories, L.p. | 2 | $38 |
| Sanofi | 1 | $31 |
| Amgen | 1 | $28 |
| Johnson & Johnson | 1 | $28 |
| Dermavant Sciences, Inc. | 1 | $28 |
| Smith+Nephew | 1 | $22 |
| Strata Skin Sciences, Inc. | 3 | $21 |
| Pfizer | 1 | $15 |
How this compares
$754 in reported general payments places this provider in the 30th percentile of 606 dermatology providers in Illinois.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Clobetasol Propionate | 134 | $4,899 |
| Ketoconazole | 141 | $1,626 |
| Econazole Nitrate | 34 | $731 |
| Halobetasol Propionate | 11 | $720 |
| Doxycycline Hyclate | 35 | $580 |
| ValacyclovirValacyclovir Hcl | 46 | $496 |
| Triamcinolone Acetonide | 31 | $426 |
| Cephalexin | 18 | $392 |
| Clindamycin Phosphate | 12 | $293 |
| Fluticasone Propionate | 19 | $274 |
| Mupirocin | 42 | $239 |
| Prednisone | 11 | $32 |
Paid to pharmacies, not to this prescriber.
Other dermatology in Crest Hill
- Steven NeubauerCrest Hill$35K
- Gayle McCloskeyCrest Hill$24K
- Ahmad AminNaperville$4.1M
- Raj ChovatiyaChicago$3.6M
- George LewittNorthbrook$3M
- Peter LioChicago$2.4M
- Elizabeth KiracofeChicago$1.6M
- Lana SchmidtEffingham$1.3M
- Melissa AbramsVernon Hills$600K
- Carolyn JacobChicago$566K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.